Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 30;12(10):1920-1925.
doi: 10.21037/tp-23-360. Epub 2023 Sep 25.

Prognostic importance of the fusion partners and measurable residual disease in patients with acute myeloid leukemia who harbor 11q23/ KMT2A alterations

Krzysztof Mrózek  1
Affiliations
Editorial

Prognostic importance of the fusion partners and measurable residual disease in patients with acute myeloid leukemia who harbor 11q23/ KMT2A alterations

Krzysztof Mrózek. Transl Pediatr. .
No abstract available

Keywords: 11q23/KMT2A fusion partner; Acute myeloid leukemia (AML); flow cytometry; measurable residual disease (MRD); prognosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-360/coif). The author has no conflicts of interest to declare.

Comment on

References

    1. Mrózek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev 2004;18:115-36. 10.1016/S0268-960X(03)00040-7 - DOI - PubMed
    1. Harrison CJ, Hills RK, Moorman AV, et al. Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12. J Clin Oncol 2010;28:2674-81. 10.1200/JCO.2009.24.8997 - DOI - PubMed
    1. von Neuhoff C, Reinhardt D, Sander A, et al. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. J Clin Oncol 2010;28:2682-9. 10.1200/JCO.2009.25.6321 - DOI - PubMed
    1. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia 2022;36:1703-19. - PMC - PubMed
    1. Mrózek K. Molecular cytogenetics in acute myeloid leukemia in adult patients: practical implications. Pol Arch Intern Med 2022;132:16300. 10.20452/pamw.16300 - DOI - PubMed